SCHEMBL22490892

SCHEMBL22490892

CC1(C)O[C@@H]2[C@H](O1)[C@@H](OC(=O)c1ccc(OCc3ccccc3)cc1)[C@](C)(O)O[C@@H]2COO[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
HIF1A Q16665 1/20 0.37
MAOB P27338 1/20 0.37
ALDH1A1 P00352 1/20 0.36
NR4A2 P43354 2/20 0.36
NR4A1 P22736 1/20 0.36
NR4A3 Q92570 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA5 P30532 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA4 P43681 1/20 0.36
PARP10 Q53GL7 1/20 0.35
SRD5A2 P31213 1/20 0.34
PPARG P37231 1/20 0.34
NT5E P21589 1/20 0.34
EGFR P00533 2/20 0.33
LTB4R Q15722 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488462 0.75 ALDH1A1 (0.40) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL7767591 0.69 MAOB (0.46) HIF1AMAOBALDH1A1NR4A2NR4A1
SCHEMBL22490847 0.66 ALDH1A1 (0.54) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL22490882 0.66 ALDH1A1 (0.54) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL23488672 0.66 ALDH1A1 (0.54) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL23488461 0.66 ALDH1A1 (0.54) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL7768503 0.65 KMT2A (0.52) HIF1AMAOBNR4A2NR4A1NR4A3
SCHEMBL23488116 0.64 ADRB2 (0.41) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL22490885 0.64 ADRB2 (0.41) ADRB2ADRB1ADRB3HIF1AMAOB
SCHEMBL3856812 0.64 ALDH1A1 (0.46) ALDH1A1CHRNB2CHRNA7CHRNA4NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed
EP-3717463-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN Sanofi (FR) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 ADRB2 2675/4885ADRB1 2217/4885ADRB3 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.